BiologicsExtremitiesHospitalsReconSpineSports Medicine

Advanced BioMedical Technologies Inc. Completes Human Clinical Tests of PA Absorbable Orthopedic Implant Screw Required by the China State Food and Dr

SHENZHEN, CHINA and MIDDLETOWN, NY–(Marketwire – October 21, 2009) – Advanced BioMedical Technologies Inc. (OTCBB: ABMT) announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63. The Company is compiling trial reports and has entered the last stage of its clinical trial. The Company will apply for the SFDA final approval of this product as soon as the Comparison Data are prepared.

“The successful taking in of 63 clinical test cases that were conducted at SFDA appointed hospitals is a milestone in our company’s history. It symbolizes the approval of our technology by hospitals and doctors, and the acknowledgement and acceptance of our product by patients. We will commence production and marketing of our product as soon as we receive SFDA approval,” said Ms Hui Wang, CEO of Advanced BioMedical Technologies Inc.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

One Comment

Back to top button